Weaver Consulting Group

SEC CIK: 0001780055
Latest filing: Jul 29, 2026

SEC filings (opens in a new tab)

SRNE holding history

Sorrento Therapeutics, Inc. in every 13F filed by Weaver Consulting Group, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

SRNE overview All 13F holders of SRNE Full Q2 2026 holdings

Shares (Q1 2023): 0; Sold out in Q1 2023
Value: $0
% of portfolio: 0.0%
Quarters held: 2; Since Q3 2022

Holdings of SRNE by Weaver Consulting Group, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q1 2023	0	$0	0.0%	−45,600−100.0%	Sold out	Holders
Q4 2022	45,600	$40.4K	<0.1%	+35,500+351.5%	Added	Holders
Q3 2022	10,100	$16.0K	<0.1%	+10,100	New	Holders